FOCUS
ISS Research Advances Cancer Treatment
MAY 3, 2012 21:36 STAFF WRITERS 0 COMMENTS
Mice Return from Long Duration Spaceflight, Show Reproductive Effects
Sally Ride, First American Woman in Space, Dead at 61
Mission Highlights: SpaceX's Dragon Makes History
Soyuz Docks, Delivers Crew
Dr. Morrison with MEPS flight hardware ready to pack for the International Space Station UF-2 mission (Credits: NASA).
Source: NASA
Humanity is on the constant search for improvements in cancer treatments, and the International Space Station has provided a microgravity platform that has enabled advancements in the cancer treatment process.
The oncology community has a recent history of using different microencapsulation techniques as an approach to cancer treatment. Microencapsulation is a single step process that forms tiny liquid-filled, biodegradable micro-balloons containing various drug solutions that can provide better drug delivery and new medical treatments for solid tumors and resistant infections. In other words, by using microcapsules containing antitumor treatments and visualization markers, the treatment can be directed right to the tumor, which has several benefits over systemic treatment such as chemotherapy. Testing in mouse models has shown that these unique microcapsules can be injected into human prostate tumors to actually inhibit tumor growth or can be injected following cryo-surgery (freezing) to improve the destruction of the tumors much better than freezing or local chemotherapy alone. The microcapsules also contain a contrast agent that enables C-T, X-ray or ultrasound imaging to monitor the distribution within the tissues to ensure that the entire tumor is treated when the microcapsules release their drug contents.
Schematic of the Pulse Flow Microencapsulation System (Credits: NASA).
The Microencapsulation Electrostatic Processing System-II experiment, or MEPS-II, led by Dennis Morrison, Ph.D. (retired), at NASA Johnson Space Center, was performed on the station in 2002 and included innovative encapsulation of several different anti-cancer drugs, magnetic triggering particles, and encapsulation of genetically engineered DNA. The experiment system improved on existing microencapsulation technology by using microgravity to modify the fluid mechanics, interfacial behavior, and biological processing methods as compared to the way the microcapsules would be formed in gravity.
In effect, the MEPS-II system on the station combined two immiscible liquids in such a way that surface tension forces (rather than fluid shear) dominated at the interface of the fluids. The significant performance of the space-produced microcapsules as a cancer treatment delivery system motivated the development of the Pulse Flow Microencapsulation System, or PFMS, which is an Earth-based system that can replicate the quality of the microcapsules created in space.
As a result of this space station research, the results from the MEPS-II experiments have provided new insight into the best formulations and conditions required to produce microcapsules of different drugs, particularly special capsules containing diagnostic imaging materials and triggered release particles. Co-encapsulation of multiple drugs and Photodynamic Therapy, or PDT, drugs has enabled new engineering strategies for production of microcapsules on Earth designed for direct delivery into cancer tissues. Other microcapsules have now been made for treatment of deep tissue infections and clotting disorders and to provide delivery of genetically engineered materials for potential gene therapy strategies. Microcapsules that were made on the space station and are targeted at inhibiting the growth of human prostate tumors have been successfully demonstrated in laboratory settings. Although Morrison’s team had performed several similar microencapsulation experiments on space shuttle missions, because of the space station’s ability to support long-term experiments, more progress was made by the eight microencapsulation experiments conducted on the station in 2002 than from the 60+ prior experiments conducted on the four space shuttle missions — STS-77, STS-80, STS-95 and STS 107.
Microencapsulation containing anti-tumor drugs made on the space station (Credits: NASA).
Benefits of Space Station Research
The microgravity environment on the station was an enabling environment that led the way to better methods of microcapsule development on Earth. The capability to perform sequential microencapsulation experiments on board the station has resulted in new, Earth-based technology for making these unique microballoons that provide sustained release of drugs over a 12–14 day period. The station research led directly to five U.S. patents that have been licensed by NASA and two more that are pending. NuVue Therapeutics, Inc., is one of several commercial companies that have licensed some of the MEPS technologies and methods to develop new applications, such as innovative ultrasound enhanced needles and catheters that will be used to deliver the microcapsules of anti-tumor drugs directly to tumor sites. More recent research uses a new device for freezing tumors (“cryo-ablation”) followed by ultrasound-guided deposition of the multi-layered microcapsules containing different chemotherapy drugs outside the freeze zone within a human prostate or lung tumor. In a 28-day study, combination therapy resulted in retarding tumor growth 78 percent and complete tumor regression of up to 30 percent after only three weekly injections of microencapsulated drug at tiny quantities that should not have slowed down tumor growth by more than 5–10 percent. NuVue Technologies, Inc., has now obtained two U.S. patents based on the combination therapy that includes the delivery of the NASA-type microcapsules. Upon securing funding, clinical trials to inject microcapsules of anti-tumor drugs directly into tumor sites will begin at MD Anderson Cancer Center in Houston and the Mayo Cancer Center in Scottsdale, Ariz.
Other potential uses of this microencapsulation technology include microencapsulation of genetically engineered living cells for injection or transplantation into damaged tissues, enhancement of human tissue repair, and real-time microparticle analysis in flowing sample streams that would allow petrochemical companies to monitor pipeline volume flow.
Mice Return from Long Duration Spaceflight, Show Reproductive Effects
Astronaut Nicole Stott displays the Mice Drawer System on ISS during Expedition 21 (Credits: NASA). Three mice have returned to Earth alive after 91 days in space aboard the International Space Station (ISS). The ...
74 Views
Boeing X-37C Crew Vehicle
Crew carrying X-37C conceptual study (Credits: AIAA/Grantz/Boeing). As already announced by the Space Safety Magazine, Boeing is studying an X-37B derivative for cargo and crew transfer to and from the ISS. Arthur Grantz, chief ...
65 Views
Jon Collins Receives Lifetime Achievement Award for Space Safety
By Jerry HaberLeonardo da Vinci, the prototypical Italian Renaissance man ; Jon Collins, the Renaissance man of Space Safety. The International Association for the Advancement of Space Safety (IAASS) recognized the outstanding contributions of Jon ...
59 Views
Progress Cargo Ship Fails to Dock
Progress M-15M successfully completed second and third rendezvous stages before failing to dock with ISS (Credits: NASA). On July 22, the Progress M-15M cargo ship undocked from the International Space Station in preparation for ...
54 Views
Preparing for Safe Exploration of Mars
Source: David J. Geaney for Mars Travel Sometime between July 2005 and October 2008, a weak impactor broke up in the atmosphere of Mars and it's constituent parts hit the surface. Scientists know this ...
47 Views
Asteroid Zips Past Moon on July 22
Near Earth asteroid 2002 AM31 passed by Earth on July 22. At its closest approach, the city-block sized asteroid passed 5.2 km from Earth, equivalent to 13.7 lunar distances. The asteroid posed no danger to ...
47 Views
HTV-3 En Route to International Space Station
HTV-2 on the end of ISS' Canadarm 2 in 2011 (Credits: JAXA). On Saturday, July 21 the H-II Transfer Vehicle-3 (HTV-3) launched from the Tanegashima Space Center aboard a Japanese H-IIB rocket. The robotic ...
37 Views
The Longest Continuous View of Earth From Space Hits 40
Swirls of phytoplankton make a Van Gogh-like scene in thie 2005 Landsat image of Gotland, a Swedish island in the Baltic Sea (Credits: NASA). Source: NASA NASA and the Interior Department Monday marked the ...
34 Views
Next Generation Russian Crew Capsule Delayed
An interior model of the ACV (Credits: RIA Novosti). On July 18, Roscosmos chief Vladimir Popovkin announced that the Advanced Crew vessel (ACV), a six seater ship capable of flying to the moon, would ...
31 Views
Staff Writers
More Posts
Share this:
Share
TAGS: cancer, International Space Station, ISS, microencapsulation, microgravity, NASA, oncology, research
SHARE THIS ARTICLE
FACEBOOK TWITTER DELICIOUS DIGG
PREVIOUS ARTICLE
← DNA DAMAGE AMONG MAJOR THREATS OF A MARS MISSION
NEXT ARTICLE
AUSTRIAN CAVES STAND IN FOR MARS →
NO COMMENTS
LEAVE A COMMENT
Name (required)
Email (required)
Website
Notify me of follow-up comments by email.
Notify me of new posts by email.
No comments:
Post a Comment